hospitalized COVID-19 patients – Page 28 – Communicable Diseases Research

Acute kidney injury in hospitalized patients with COVID-19 (retrospective study)

Research

Published on 2021-01-122022-10-31
Journal: The Egyptian Journal of Bronchology [Category] COVID-19,

Longitudinal Monitoring of Lactate in Hospitalized and Ambulatory COVID-19 Patients

입원 및 보행 중인 COVID-19 환자에서 젖산의 종단적 모니터링

Clinical Trial

Published on 2021-01-112022-09-11
Journal: The American Journal of Tropical Medicine and Hygi [Category] 바이오마커, 임상,

SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype

SARS-CoV-2 감염은 전혈전성 혈소판 표현형과 관련이 있습니다

Article

Published on 2021-01-052022-09-11
Journal: Cell Death & Disease [Category] 치료기술,

[키워드] abnormal coagulation Activation addition Adhesion Molecule adhesion molecules antibodies antiplatelet Antithrombotic cardiovascular complications CD63 characterized Coagulation complex condition contribute Control coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients COVID-19 sample COVID-19 samples Cytometry donors expressed expression healthy control healthy controls hospitalized COVID-19 patient hospitalized COVID-19 patients hypercoagulable Hypercoagulable state in vitro incidence intensity intensive care intensive care support interactions investigated involved LAMP marker mass Mechanisms of disease median novel Novel coronavirus novel coronavirus disease P-selectin parameter patients peptide phenotype phenotypical Platelet platelet activation Platelets pro-thrombotic reduced Research SARS-COV-2 infection selectin signal intensity significantly Stimulation Support thrombin thrombin receptor transmembrane protein TRAP Treatment viral infection
[DOI] 10.1038/s41419-020-03333-9 PMC 바로가기 [Article Type] Article

COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation

코로나19와 중추신경계의 상호작용: 임상 증상을 넘어선 큰 그림

Review

Published on 2021-01-012022-09-11
Journal: Journal of biosciences [Category] 유전자 메커니즘, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Anosmia Asymptomatic Ataxia Case report caused Central nervous system clinical symptom Clinical symptoms CNS Coagulation coagulation pathway Complete Contact coronavirus coronavirus disease Coronavirus-2 COVID-19 COVID-19 patient COVID-19 patients Crosstalk cytokine Cytokine storm Disease progression dysgeusia dysregulation effective greater heart hospitalized COVID-19 patients HPA hypoxia immunological responses impairment infected patient infected patients knowledge Lungs major organ mechanism mode multiplication neurotropic offer pandemic pathway Psychological psychological status report Research research finding respiratory SARS-CoV2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus the SARS-CoV-2 Treatment Viral viral entry Viral load
[DOI] 10.1007/s12038-021-00165-3 PMC 바로가기 [Article Type] Review

Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG

고역가 항중증급성호흡기증후군 코로나바이러스 2(SARS-CoV-2) 스파이크 단백질 IgG를 포함하는 회복기 혈장으로 조기에 수혈된 환자

Article

Published on 2021-01-012022-09-12
Journal: The American journal of pathology [Category] SARS, 진단,

Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients

COVID-19 환자의 뇌 손상 감지를 위한 혈액 바이오마커

Review

Published on 2021-01-012022-09-10
Journal: Journal of Neurotrauma [Category] MERS, 바이오마커, 유전자 메커니즘, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Affect analyzed approved Biomarker Blood blood biomarkers Brain Cardiac arrest cerebrospinal fluid Clinical practice CNS CNS injury coronavirus coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 patients CSF description detect detection diagnose Diagnosis diagnostic Diseases drug Drug administration Efficacy Elevation elevations ENhance epilepsy food GFAP, SARS-CoV-2 highlight hospitalized COVID-19 patient hospitalized COVID-19 patients Human immunodeficiency virus hypoxia immunodeficiency virus improvement Improvements Infection Infectious diseases Injury management mechanism Meningitis Mild moderate multiple organ multiple organs mutability nervous system neurological Neurological deficit neurological deficits outcome Pathways Patient Patient management patients predict Protein rationale reported Research respiratory SARS-CoV-2 SARS-CoV-2 virus severe acute respiratory syndrome Coronavirus severity stroke Symptom the disease therapeutic intervention therapeutic interventions Traumatic brain injury treat Triage tuberculous tuberculous meningitis U.S. Food and Drug Administration UCH-L1 urgency Viral virus virus attack virus attacks
[DOI] 10.1089/neu.2020.7332 PMC 바로가기 [Article Type] Review

Association of liver steatosis and fibrosis with clinical outcomes in patients with SARS-CoV-2 infection (COVID-19)

SARS-CoV-2 감염(COVID-19) 환자의 임상 결과와 간 지방증 및 섬유증의 연관성

Article

Published on 2021-01-012022-09-11
Journal: Annals of hepatology [Category] SARS, 바이오마커,

A Retrospective Look at Recent COVID-19 Articles Published in Cell Transplantation: Research Leading to Further Understanding

세포 이식에 게재된 최근 COVID-19 기사에 대한 회고적 검토: 더 많은 이해를 이끄는 연구

Article

Published on 2021-01-012022-09-11
Journal: Cell transplantation [Category] 변종,

[키워드] ACE2 acute respiratory diseases androgen Androgen receptors angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 article cell transplantation cellular cellular therapy Characteristics consequence COVID-19 COVID-19 pandemic COVID-19 severity Cytokines disease disease severity enzyme Genes group Hospitalization hospitalized COVID-19 patient hospitalized COVID-19 patients immune infused Intervention leading mesenchymal stem cell Mesenchymal stem cells modulating MSC offered pandemic Perspective principle proof recent receptor reduced Research respiratory diseases SARS-CoV2 Serine stem cells supported the disease therapy TMPRSS2 transmembrane serine protease transplantation Treatment understanding unique Variability variant variants
[DOI] 10.1177/09636897211049814 PMC 바로가기 [Article Type] Article

Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis

2019년 코로나바이러스 감염증(COVID-19) 환자 사망률에 대한 아지트로마이신 유무에 따른 하이드록시클로로퀸의 영향: 체계적인 검토 및 메타 분석

Meta-Analysis

Published on 2021-01-012022-09-11
Journal: Clinical microbiology and infection : the official [Category] 신약개발, 치료제,

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis Antiviral effect articles Azithromycin Bayesian meta-analysis Chloroquine Cochrane Library Combination conducted control group controlled trials coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 mortality Critical disease Effect effect sizes eligibility evaluated Google Scholar hospitalized COVID-19 patient hospitalized COVID-19 patients hospitalized patient hospitalized patients Hydroxychloroquine hydroxychloroquine group in vitro inclusion criteria increased mortality initial search medRxiv Meta-analysis moderate Mortality mortality rate Multiple non-randomized trial observational studies participant Patient patients treated promoted random-effects model Randomized controlled trials reduced Relative risk respiratory risk risk of bia Risk of bias SARS-CoV-2 searched severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly significantly increased Standard of care systematic review treat Web of Science
[DOI] 10.1016/j.cmi.2020.08.022 PMC 바로가기 [Article Type] Meta-Analysis

Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19

COVID-19로 입원한 성인에서 중등도 용량의 코르티코스테로이드 치료

Article

Published on 2021-01-012022-09-11
Journal: Clinical microbiology and infection : the official [Category] SARS, 치료제,

[키워드] 1:1 95% CI Administered administration Admission Adult patients Analysis association clinical effectiveness Clinical improvement Clinical outcome clinical outcomes coronavirus disease Coronavirus disease 2019 Corticosteroid corticosteroid therapy corticosteroid treatment Corticosteroids corticosteroids therapy covariate COVID-19 COVID-19 patient COX Cox proportional hazard Cox proportional hazards regression model dead death rate discharged dose hazard high-flow oxygen therapy Hospitalized hospitalized COVID-19 patients In-hospital death in-hospital mortality IQR log rank mechanical ventilation Mortality multivariable nasal no significant difference no significant differences outcome oxygen Oxygen therapy Patient patients performed propensity score matching proportional hazards model Regression model required retrospective cohort study SARS-CoV-2 SARS-CoV-2 pneumonia significant differences Treatment was used with COVID-19
[DOI] 10.1016/j.cmi.2020.09.045 PMC 바로가기 [Article Type] Article